Chemotherapy-induced peripheral neuropathy.
Recent advances in the development and administration of chemotherapy for malignant diseases have led to prolonged survival of patients and the promise of a return to normal lives. This progress comes with a price, however, and the nervous system is frequently the target of therapy-induced toxicity. Unlike more immediate toxicities that affect the gastrointestinal tract and bone marrow, chemotherapy-induced neurotoxicity is frequently delayed in onset and may progress over time. In the peripheral nervous system, the major brunt of the toxic attack is directed against the peripheral nerve, targeting the neuronal cell body, the axonal transport system, the myelin sheath, and glial support structures, resulting in chemotherapy-induced peripheral neuropathy.
Malik
Bushra
B
Section of Headache and Pain, Department of Neurology, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Stillman
Mark
M
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced* / Q000473:pathology / Q000517:prevention & control; D011984:Sensory Receptor Cells / Q000187:drug effects / Q000502:physiology
D000970:Antineoplastic Agents
Muscle Nerve. 2005 Jul;32(1):51-60
15880395
Neurology. 1995 Oct;45(10):1848-55
7477980
Arch Neurol. 2003 Nov;60(11):1524-34
14623723
BMC Cancer. 2006 Jan 07;6:5
16398939
Neurol Clin. 2003 Feb;21(1):279-318, x
12690653
J Neurol. 1994 Jun;241(7):432-5
7931444
Clin Cancer Res. 2005 Jul 1;11(13):4843-50
16000582
Brain. 2007 Apr;130(Pt 4):1076-88
17301082
Rev Neurol (Paris). 1985;141(10):614-26
3003868
Eur J Cancer. 2005 Aug;41(12):1746-50
16039110
Cleve Clin J Med. 2006 Aug;73(8):726-8, 729-30, 733-6 passim
16913197
Neurology. 1999 Nov 10;53(8):1634-40
10563605
Neurology. 1989 Mar;39(3):368-73
2564647
Curr Pain Headache Rep. 2006 Aug;10(4):279-87
16834943
Ann Oncol. 2000 May;11(5):509-13
10907941
Neurosci Lett. 2006 Apr 24;397(3):219-23
16406309
Support Care Cancer. 2005 Aug;13(8):647-51
15711945
J Neurol. 2002 Jan;249(1):9-17
11954874
Neurology. 2002 Dec 24;59(12):1872-5
12499476
Ann Oncol. 1998 Jul;9(7):739-44
9739440
Muscle Nerve. 2004 Mar;29(3):387-92
14981738
Lancet. 2003 Jun 21;361(9375):2099-106
12826431
Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4055-61
15217938
Minerva Anestesiol. 2006 Mar;72(3):151-69
16493391
Pain. 2004 May;109(1-2):132-42
15082135
Brain. 1996 Dec;119 ( Pt 6):2039-52
9010008
J Clin Oncol. 2002 Aug 15;20(16):3478-83
12177109
Clin Cancer Res. 2005 Mar 1;11(5):1685-6
15755987
Clin Cancer Res. 2006 Apr 15;12(8):2607-12
16638873
Neurology. 2003 Jan 28;60(2):337-40
12552058
J Peripher Nerv Syst. 2006 Jun;11(2):135-41
16787511
Anticancer Drugs. 2005 Jun;16(5):587-91
15846125
Neurology. 2005 Jan 11;64(1):26-31
15642899
Curr Oncol Rep. 2005 May;7(3):159-60
15847705
Neurology. 1996 Jan;46(1):108-11
8559355
Cancer Invest. 2004;22(3):471-3
15493367
Semin Neurol. 1987 Mar;7(1):58-66
3332448
Semin Neurol. 2005 Jun;25(2):204-16
15937736
Clin Cancer Res. 2004 Jan 15;10(2):461-7
14760066
J Neurooncol. 1997 Oct;35(1):47-53
9266440
Cancer. 1996 Apr 1;77(7):1356-62
8608515
Clin Oncol (R Coll Radiol). 2005 Jun;17(4):271-6
15997923
Neurology. 2003 Nov 11;61(9):1297-300
14610145
Clin Cancer Res. 2005 Mar 1;11(5):1691-3
15755989
Clin Cancer Res. 2005 Mar 1;11(5):1890-8
15756015
Br J Cancer. 1997;75(3):417-22
9020489
J Clin Oncol. 2003 Mar 1;21(5):927-31
12610195